Trials / Enrolling By Invitation
Enrolling By InvitationNCT04575688
Periarticular Injection Versus Popliteal Block
A Randomized Controlled Trial Comparing a Periarticular Injection to a Popliteal Block for Pain Control in Ankle/Hindfoot Osteotomy or Fusion and Ankle Fractures
- Status
- Enrolling By Invitation
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Campbell Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the effectiveness and safety of two standard of care perioperative procedures for controlling pain following ankle and hindfoot osteotomy or fusion or ankle fracture repair.
Detailed description
This is a prospective, randomized, controlled research study of two perioperative standards of care for managing post operative pain. The first standard of care procedure is the periarticular injection; the second is the popiteal block.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exparel | Exparel will be administered by periarticular injection to patients undergoing hindfoot osteotomy or fusion, ankle osteotomy or fusion, or ankle fracture repair. |
| DRUG | Bupivicaine | Bupivicaine will be administered by popliteal block to patients undergoing hindfoot osteotomy or fusion, ankle osteotomy or fusion, or ankle fracture repair. |
Timeline
- Start date
- 2021-07-13
- Primary completion
- 2026-09-30
- Completion
- 2027-02-28
- First posted
- 2020-10-05
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04575688. Inclusion in this directory is not an endorsement.